Jose M. Galarza

Principal investigator.

BiotechORCID
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$1.8MFederal grants as PI3 awards
7Patents grantedLatest Dec 20, 2022
25Papers1,215 citations
Career record

Federal awards and patents by year

20162022
AwardsPatents
Federal awards as principal investigator

3 awards · $1.8M

DateAgencyAwardAmountCompany
Aug 3, 2020NIHSBIR Phase I
Production and Testing of VLP-based RSV Vaccine
$300KTECHNOVAX INC
Aug 1, 2019NIHSBIR Phase II
Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.
$734KTECHNOVAX INC
Aug 28, 2018NIHSBIR Phase II
Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.
$747KTECHNOVAX INC
Patents

8 patents as inventor

Matched by the first inventor’s name and the patent’s company.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#1,184
Awards as PI#822
Patents#12
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.